New York Cut Drunk-Driving Deaths. Alcohol Deaths Rose 18.5% Anyway
New York's alcohol-impaired road death rate fell 3% over a decade while alcohol-induced deaths jumped 18.5%. The state's addiction strategy never caught up.
New York has spent a decade building machinery to stop one kind of alcohol death, and the machinery works. The rate of alcohol-impaired road deaths in the state fell 3.12% between 2015 and 2024, from 1.55 to 1.50 per 100,000 residents, the fifteenth-largest decline among the fifty states.
Over the identical ten years, the state's age-adjusted rate of alcohol-induced deaths rose 18.46%, from 6.5 to 7.7 per 100,000. That is 1.2 additional deaths per 100,000 residents every year, and it ranked New York 43rd nationally for growth in that measure. Both figures come from a state-by-state comparison by Lantana Recovery, a treatment provider that built its analysis from federal mortality and crash records covering 2015 through 2024, and reported this week by the Staten Island Advance.
Same state. Same decade. Same molecule. Opposite directions.
The split is not a paradox, and it is not evidence that New Yorkers started driving better while drinking more. It is evidence that the state built a system for the alcohol harm that produces a defendant and built almost nothing for the alcohol harm that produces a chart in a hepatology clinic.
What the Two Numbers Actually Measure
The two rates are not two views of one problem. They are drawn from different datasets with different rules for what counts.
Alcohol-impaired road deaths come from crash records, in which a driver's blood alcohol concentration is a fact entered into a report. Alcohol-induced deaths come from vital statistics, where a death is counted only when the underlying cause is a condition wholly attributable to alcohol: alcoholic liver disease, alcohol poisoning, alcoholic cardiomyopathy, alcohol dependence, and a short list of related codes. That narrow definition is why the New York figure is 7.7 per 100,000 and not something larger.
The broader federal estimate is much larger. The CDC puts deaths from excessive alcohol use at about 178,000 a year for 2020 and 2021, roughly 5% of all deaths in the United States, an increase of about 29% over 2016 and 2017. That works out to more than 488 deaths a day, or about twenty every hour, and it shortens the lives of those who die by an average of 24 years, for a total of roughly 4 million years of potential life lost.
| Measure | 2015 | 2024 | Change |
|---|---|---|---|
| New York alcohol-impaired road deaths, per 100,000 | 1.55 | 1.50 | −3.12% |
| New York alcohol-induced deaths, age-adjusted, per 100,000 | 6.5 | 7.7 | +18.46% |
| U.S. deaths from excessive alcohol use, annual | — | ~178,000 | +29% vs. 2016–2017 |
Read together, the crude rate and the narrow definition point the same way. New York's alcohol death problem did not shrink while its road problem shrank. It grew, and the narrower measure almost certainly understates how much.
Why the Road Numbers Moved
Driving after drinking is the rare alcohol harm with a victim, a location, an investigating officer, and a statute attached. That makes it governable in ways that cirrhosis is not.
Nationally the toll remains enormous. NHTSA counted 11,904 people killed in alcohol-impaired driving crashes in 2024, about 32 a day, or one person every 44 minutes. Those deaths were roughly 30% of all traffic fatalities, and the ten-year average from 2015 to 2024 was over 11,500 a year.
Against that backdrop, a 3.12% decline over a decade is real but modest. It is the product of a policy stack that took decades to assemble: the 0.08 blood alcohol standard, administrative license revocation, sobriety checkpoints, ignition interlocks, and the slow cultural drift that made a designated driver unremarkable. Each element depends on the same lever, which is that the behavior is observable and the consequence is a crash somebody has to respond to.
New York's progress on that lever placed it fifteenth in the country. Its progress on the other measure placed it forty-third. The gap between those two ranks is the story.
Where Alcohol Deaths Actually Come From
About two-thirds of alcohol-attributable deaths are chronic. The CDC's breakdown of its 178,000 annual estimate assigns roughly 117,000 to conditions that develop from drinking over time — several cancers, heart disease, liver disease, alcohol use disorder itself — and about 61,000 to acute events such as motor vehicle crashes, alcohol-involved drug overdoses, alcohol poisonings, and suicide.
The chronic category is where New York's rising rate lives. It is also the category that generates no 911 call, no arrest, and no press conference. A person who dies of alcoholic liver disease after fifteen years typically dies in a hospital bed, weeks after a discharge that was coded as something else, and the death certificate may or may not capture alcohol as the underlying cause.
The scale of the mortality is not in dispute even where the counting is imperfect. Alcohol-attributable deaths rose faster among women than men between the two CDC measurement periods, up 35% among girls and women against 27% among boys and men, and the leading causes include breast and colorectal cancer alongside liver disease. New York's 7.7 per 100,000 is a floor assembled from the clearest cases.
The Medication That Bends This Curve
Three medications carry FDA approval for alcohol use disorder, and all three have been available for years. Naltrexone was approved orally in 1994 and as a long-acting injectable in 2006. Acamprosate followed in 2004. Disulfiram, the oldest, dates to 1951. They reduce craving and heavy drinking, they are not addictive, and naltrexone can be prescribed by any clinician with a DEA number.
The bottleneck is not the pharmacy. It is the facility.
A JAMA Network Open analysis published in January and covering 3,153 counties across roughly 22,000 county-years found that the share of counties with at least one substance use disorder treatment facility offering these medications rose from 34% in 2017 to 44% in 2021, then stopped rising. Through 2023, the line stayed flat.
Where Access Stalls
The same study found the flatness was not evenly distributed. Facilities offering medications for alcohol use disorder were concentrated in metropolitan counties with larger populations and lower shares of uninsured residents. Rural counties, smaller counties, and socioeconomically disadvantaged counties were significantly less likely to have any facility offering them at all.
That pattern does not describe a New York measurement, and it should not be read as one. But it describes a state whose map includes the Adirondacks, the North Country, the Southern Tier, and a long rural spine where a clinic offering naltrexone may be an hour away and a bottle of vodka is at the corner store. New York's alcohol-induced death rate is a statewide average. Averages of that kind hide their own geography.
Alcohol Inside the Opioid Decline
New York's signature addiction success is genuine. Provisional CDC figures highlighted by the Governor's office show overdose deaths in the state fell for a third consecutive year, down 44.9% since 2022 — more than 5,000 lives — with opioid-related deaths down 51.9%. The announcement credits expanded medication treatment, harm reduction supplies mailed directly to homes, and a sustained investment campaign.
That success is worth stating plainly, and it is worth noting the same announcement included a caution from State Senator Gustavo Rivera that his constituents in the Bronx had not seen the same decline.
What the announcement did not address is that the two crises overlap. The National Institute on Alcohol Abuse and Alcoholism estimates that alcohol played a role in about 16% of deaths from opioid overdose in 2022, and in at least 8.4% of emergency department visits. Roughly one in six overdose deaths had alcohol somewhere in the chain.
Which means part of the falling opioid curve is an alcohol curve that has not fallen. When a person dies with both fentanyl and alcohol in their system, the death is counted as an overdose, investigated as an overdose, and reported as progress when the count drops. The drinking that made the overdose more likely in the first place gets absorbed into a different ledger.
What New York Counts, and What It Doesn't
New York publishes a real-time overdose death dashboard. It does not publish an equivalent for alcohol. Overdose fatalities arrive through medical examiners and get counted within weeks, which is what makes them available for press releases, budget justifications, and the political rhythm of an epidemic. Alcohol mortality arrives through vital statistics, which move at the speed of death certificate completion and annual tabulation.
That asymmetry is not a scandal. It is an administrative fact with consequences, because the thing a state can count quickly is the thing a state can respond to quickly.
The Denominator Problem
New York operates one of the country's largest addiction treatment systems, with a Medicaid benefit that covers alcohol treatment and its medications. The capacity exists. What the access data suggest is that capacity is unevenly stocked with the specific intervention that works, and that the geography of the gap matches the geography of the deaths.
The practical difference between a county with a naltrexone prescriber and one without is not abstract. It is whether a person who decides on a Tuesday to stop drinking has somewhere to go on Wednesday, or whether the decision expires before the appointment.
The Measure That Matters
New York has proved, at scale and against a synthetic opioid that killed faster than anything in its history, that it can bend an addiction mortality curve. The state did it with medication access, harm reduction, and money, and the 51.9% decline in opioid deaths is the proof of concept.
Alcohol is the older problem and the larger one. It kills through the liver and the heart and the breast and the colon, over years, in people whose deaths are recorded as organ failure rather than as addiction. It kills 178,000 Americans a year, and the state's age-adjusted rate for the clearest subset of those deaths has risen from 6.5 to 7.7 per 100,000 in a decade when almost everything else in New York's addiction landscape moved in the other direction.
Nothing about that number is inevitable. The medication exists, the prescribers exist, and the state has already demonstrated it knows how to reach people at scale. What is missing is the decision to treat alcohol as the epidemic it is rather than as the background condition against which the opioid epidemic happened.
New Yorkers who need help with alcohol can call the OASAS HOPEline at 1-877-846-7369, or find treatment through OASAS. Free and low-cost care is available regardless of insurance status.
Written by
MTNYC Editorial TeamThe MTNYC Editorial Team is a group of healthcare writers, researchers, and addiction specialists dedicated to providing accurate, compassionate, and evidence-based information about addiction treatment and recovery resources in New York State.
